Recent Reports

ICER’s report reviewed evidence on ten abuse-deterrent formulations (ADF) of opioids. Nine of the drugs were extended release (ER) opioids, and one was immediate release (IR). The report assessed evidence on how effectively the drugs reduce abuse of opioids at both the individual patient and population levels.

View More on this Topic

ICER’s final report on treatment for osteoporosis. This report includes a summary of a public meeting of the California Technology Assessment Forum

View More on this Topic

ICER’s Draft Evidence Report on treatments for ovarian cancer, open to public comment until August 9, 2017. For more information on submitting a public comment, please visit our stakeholder engagement page.

View More on this Topic

Materials

CTAF

Chronic Low Back and Neck Pain: Model Analysis Plan

New England CEPAC

Hemophilia A: Stakeholder List

New England CEPAC

Hemophilia A: Open Input

New England CEPAC

Abuse-deterrent opioids: Report-at-a-Glance

CTAF

Osteoporosis: Report-at-a-Glance

New England CEPAC

Abuse-Deterrent Opioids: Evidence Presentation

CTAF

CAR-T Therapies: Stakeholder List

CTAF

CAR-T: Draft Scoping Document

CTAF

CAR-T: Open Input Period

New England CEPAC

Tardive Dyskinesia: Model Analysis Plan

New England CEPAC

Tardive Dyskinesia: Research Protocol

CTAF

Chronic Low Back and Neck Pain: Research Protocol